Description
Inlyta, also known as Axitinib 5 mg tablets, is a medication used to treat advanced kidney cancer that has not responded to other treatments. It is a type of drug called a kinase inhibitor that works by blocking the signals that cause tumors to grow and spread.
Axitinib is an oral medication taken twice daily with or without food. The dosage may vary depending on the patient’s medical condition and response to treatment. It is important to follow the doctor’s instructions carefully and not stop taking the medication unless directed to do so by a healthcare professional.
This medication is usually prescribed after other treatments for advanced kidney cancer such as surgery, radiation, or chemotherapy have been unsuccessful. It has been shown to slow the progression of cancer and improve survival rates in some patients.
Inlyta, like any medication, has potential side effects. The most common side effects include diarrhea, high blood pressure, fatigue, nausea, and loss of appetite. Other less common side effects include bleeding, liver problems, thyroid problems, and neurological side effects.
Before taking Inlyta, patients should inform their doctor of any medical conditions they have, including liver or kidney disease. They should also disclose any medications they are taking, including over-the-counter supplements and herbal remedies, as they may interact with Inlyta and cause adverse effects.
In conclusion, Inlyta is an important medication used to treat advanced kidney cancer. Patients should take the medication as directed and report any concerning symptoms to their healthcare provider. With proper medical guidance, Inlyta can be an effective tool in managing serious health conditions.
Reviews
There are no reviews yet.